ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,025,761 | -43.1% | 200,686 | -20.0% | 0.02% | -40.0% |
| Q2 2023 | $7,079,497 | +97.0% | 250,957 | +20.1% | 0.04% | +66.7% |
| Q1 2023 | $3,593,390 | -22.2% | 208,918 | -8.9% | 0.02% | -38.5% |
| Q4 2022 | $4,619,069 | +16.0% | 229,348 | +24.8% | 0.04% | -7.1% |
| Q3 2022 | $3,981,000 | +13.1% | 183,785 | +46.7% | 0.04% | +31.2% |
| Q2 2022 | $3,519,000 | -37.1% | 125,247 | +3.4% | 0.03% | -3.0% |
| Q1 2022 | $5,591,000 | +2.0% | 121,170 | +85.8% | 0.03% | +13.8% |
| Q4 2021 | $5,481,000 | +118.8% | 65,199 | +73.5% | 0.03% | +70.6% |
| Q3 2021 | $2,505,000 | +1.4% | 37,588 | -19.1% | 0.02% | +6.2% |
| Q2 2021 | $2,471,000 | -13.1% | 46,448 | -29.1% | 0.02% | -15.8% |
| Q1 2021 | $2,843,000 | +788.4% | 65,526 | +964.9% | 0.02% | +533.3% |
| Q4 2020 | $320,000 | – | 6,153 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,664,409 | $177,556,000 | 4.47% |
| Avidity Partners Management LP | 2,493,800 | $166,187,000 | 3.68% |
| Matrix Capital Management Company, LP | 4,349,279 | $289,836,000 | 3.30% |
| Integral Health Asset Management, LLC | 90,000 | $5,998,000 | 1.72% |
| Affinity Asset Advisors, LLC | 77,500 | $5,165,000 | 1.30% |
| Ghost Tree Capital, LLC | 65,000 | $4,332,000 | 1.27% |
| Ikarian Capital, LLC | 200,000 | $13,328,000 | 0.94% |
| HighVista Strategies LLC | 20,596 | $1,373,000 | 0.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 23,855 | $1,590,000 | 0.90% |
| Woodline Partners LP | 507,847 | $33,843,000 | 0.55% |